Boehringer Ingelheim International GmbH - Company Profile
Powered by 
All the sales intelligence you need on Boehringer Ingelheim International GmbH in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Boehringer Ingelheim International GmbH fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Boehringer Ingelheim International GmbH.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Boehringer Ingelheim International GmbH patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390109A1 | Application | Administration device for in particular intravitreal administration of a fluid | A61F9/0017; A61M5/2033; A61M5/3146 | December 07, 2023 |
| US20230392147A1 | Application | Mammalian cells for producing a secreted protein | C12N15/11; C12N15/113; C12N15/1137; C12N2310/122; C12N2310/14; C12N2310/20; C12N2310/531; C12N2510/02; C12N2800/80; C12N9/1088; C12N9/22; C12Y205/01018; C07K14/4705; C07K16/00; C07K2319/00 | December 07, 2023 |
| US20230395227A1 | Application | System and method for measuring the treatment effect of a drug | G16H10/20; G16H20/10; G16H50/50; G16H50/70 | December 07, 2023 |
| EP4045053B1 | Grant | Neuartige tetrazole und ihre verwendung als trpa1 hemmer | A61K31/522; A61K31/53; A61P11/00; A61P11/06; A61P13/00; A61P17/00; A61P25/28; A61P29/00; A61P37/02; C07D473/30; C07D473/32; C07D487/04; C07D513/04 | December 06, 2023 |
| EP4284511A1 | Application | Chinoline und azachinoline als inhibitoren von cd38 | A61P35/00; C07D401/04; C07D401/14; C07D405/14; C07D471/04; C07D487/04 | December 06, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer